China Decode: What's at Stake Ahead of Trump and Xi's September Meeting, and China's Biotech Surge

Alice Han and James Kynge preview President Trump and President Xi’s September 24 meeting in Washington, set against a flurry of Xi’s diplomatic activity and shifting trade leverage around rare earths, soybean purchases, and the AI arms race. Then, Ruby Wang joins to discuss China’s biotech boom — how faster, cheaper clinical trials and billions in licensing deals have turned the country into a global pharma challenger, and what it means for U.S. competitiveness. A timely look at the broader US-China rivalry beyond the trade deficit.